The prevalence of obesity in Scotland has reached alarming proportions; with the impact on physical and mental well-being being recognized at a national level. Naturally, the financial impact of treating obesity and obesity-related disease is substantial. In Scotland in 2001, the NHS cost was estimated at £171 million.
Obesity is defined as a disease process characterized by excessive body fat accumulation with multiple organ-specific consequences.The Scottish Intercollegiate Guidelines Network (SIGN) has provided evidence based recommendations on the prevention and treatment of obesity within the clinical setting, in children, young people and adults. The guideline development group has highlighted specific recommendations and good practice points that should be prioritized for implementation.The key recommendations are as follows:
RioMed’s Cellma provides fully customized assessments to facilitate the patient’s entire journey through your practice. This would allow for proper evaluation of the patient’s improvement or deterioration in health. Very important to dealing with persons suffering from obesity is the careful examination and possible adjustments to their lifestyle. Cellma assessments allow for the documentation of this information for the purpose of both individual and clinical evaluations and restructuring. Patient and service dashboards would facilitate the evaluation of which methods of treatment prove to be most effective, as well as highlight trends that would encourage innovation in terms of methods of treatment.For more information: Obesity Guidelines
|Last Updated ( Monday, 07 February 2011 )|